Kamal Therapeutics, Inc.
PrivateLast Round
Early Funding
Nov 10, 2025
Total Funding Raised
$21.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kamal Therapeutics, Inc. is a biotechnology company developing intravenous recombinant human decorin to treat dystrophic epidermolysis bullosa.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kamal Therapeutics, Inc. Comparables
Compare Kamal Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopewell Therapeutics | 90% | |
| Orion Therapeutics | 89% | |
| NanoVation Therapeutics | 87% |
Kamal Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 10, 2025 | ||||
| Seed | Dec 1, 2019 |
Kamal Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EB Research Partnership | Seed |
| Congressionally Directed Medical Research Programs | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
$14M raised in early funding.
- Dec 1, 2019
$7.2M raised from multiple government and non-profit investors.
Kamal Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kamal Therapeutics, Inc.'s valuation, stock price, and market status.
Is Kamal Therapeutics, Inc. a public or private company?
Kamal Therapeutics, Inc. is a private company.
What is the current stock price of Kamal Therapeutics, Inc.?
Kamal Therapeutics, Inc. is a private company with no public stock price. Caplight tracks Kamal Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Kamal Therapeutics, Inc. worth (valuation)?
Valuation information for Kamal Therapeutics, Inc. is not publicly available.
Can I buy Kamal Therapeutics, Inc. stock?
Kamal Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kamal Therapeutics, Inc.'s last funding round?
Kamal Therapeutics, Inc.'s most recent funding round was Early Funding on November 10, 2025.
Who are the main investors in Kamal Therapeutics, Inc.?
Key investors in Kamal Therapeutics, Inc. include EB Research Partnership, Congressionally Directed Medical Research Programs.
Will Kamal Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Kamal Therapeutics, Inc..
How can I track Kamal Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kamal Therapeutics, Inc.'s secondary market activity and sign up for updates.